Marker Therapeutics (MRKR) Other Operating Expenses (2010 - 2025)
Marker Therapeutics (MRKR) posted quarterly Other Operating Expenses of $453135.0 for Q1 2025, down 99.61% quarter-over-quarter from $116.0 million in Q4 2018.
Marker Therapeutics (MRKR) Other Operating Expenses (2010 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has reported Other Operating Expenses for 7 consecutive years, with $453135.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other Operating Expenses changed N/A year-over-year to $453135.0; the TTM figure through Dec 2025 stood at $453135.0 (changed N/A YoY), while the FY2025 annual figure was $453135.0, changed N/A from the prior year.
- Other Operating Expenses fell to $453135.0 in Q1 2025 per MRKR's latest filing, from $116.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $453135.0 in Q1 2025 and bottomed at $453135.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 453,135.00 |
| Dec 31, 2018 | 116.04 Mn |
| Sep 30, 2014 | -94,640.00 |
| Jun 30, 2014 | 920,233.00 |
| Sep 30, 2013 | 212,823.00 |
| Jun 30, 2013 | 532,619.00 |
| Mar 31, 2013 | 699,023.00 |
| Dec 31, 2012 | 857,192.00 |
| Sep 30, 2012 | 457,390.00 |
| Mar 31, 2012 | 414,426.00 |
| Dec 31, 2011 | 572,980.00 |
| Sep 30, 2011 | 583,060.00 |
| Mar 31, 2011 | 1.04 Mn |
| Dec 31, 2010 | 1.22 Mn |
| Sep 30, 2010 | 1.11 Mn |
| Jun 30, 2010 | 1.08 Mn |